Nicholls, A. C. and Horsfield, K. (1976) . Thorax, 31, [289] [290] [291] [292] [293] . Serological diagnosis of tuberculosis: a report of 12 months' clinical experience. This study reports the use of an agglutination test as a routine diagnostic aid for tuberculosis. We have found this to be both useful and reliable in clinical practice. The overall reliability was greater than 90%, 13 false results being obtained in the 222 patients tested. False negatives (4) were less common than false positives (9) . The major advantage of the test is its speed, serological diagnosis being available overnight as compared with an average of one month for diagnosis by culture.
The diagnosis of tuberculosis in many cases still poses a clinical problem and the need for more rapid diagnostic procedures has long been apparent. Many authors have reported serological tests which have appeared reliable when employed against sera from patients with known diagnoses (Middlebrook and Dubos, 1948; Parlett and Youmans, 1959; Takahashi, 1962; Lind, 1964; Duboczy and White, 1966; Wallace et al., 1966; Cole, Lazarus, and Hedrick, 1972;  Affronti, Fife, and Grow, 1973; Nassau, Parsons, and Johnson, 1975; Nicholls, 1975) but none of these has proved of sufficient clinical usefulness to become universally adopted.
An initial study in this laboratory (Nicholls, 1975) has suggested that the agglutination test might be useful in the diagnosis of tuberculosis. In that study 168 of 171 control subjects gave negative serological results while 59 of 63 patients with culture-positive disease gave positive results. The purpose of the present study was to test the usefulness of the agglutination reaction in the clinical situation before a diagnosis had been made.
MATERIAL AND METHODS
During this period sera from 222 patients, in all of whom tuberculosis was a possible diagnosis, were examined. Sputum, cerebrospinal fluid, pleural fluid, urine and biopsy specimens taken for examination were subjected to microscopy for acid and alcohol-fast bacilli (AAFB) and were cultured on Lowenstein-Jensen slopes, prepared according to the recommendations of the International Union against Tuberculosis (Jensen, 1955) . Cultures were incubated at 37'C and were examined weekly. Slopes showing no growth were retained for a minimum of 12 weeks. Serum for examination was separated by centrifugation from a 10 ml venous blood sample. Serial samples were, where possible, taken at intervals of 7 to 10 days. Agglutination tests were carried out by the method previously described by Nicholls (1975) . A rising agglutinin titre is defined in this study as a difference of two or more dilutions in the titres of serial samples.
RESULTS
The results of the initial agglutinin estimations on each patient are recorded in Table I . A positive serological result was one in which the agglutinin titre to Mycobacterium tuberculosis was 1/125 or higher. The results are divided into five groups on the basis of serology and culture results. Group I consists of patients with both positive serology and culture results; group II, patients with both negative serology and culture results; group III, patients with negative serology but positive culture results; and group IV, patients with positive serology but negative culture results. Group V consists of patients who had positive culture results but from whom initial serum samples had agglutinin titres of less than 1/125. All of these patients had serial serum samples examined, and in all patients titres of 1/ 125 or more were recorded in subsequent serum samples. 289 Group I consists of 42 patients with tuberculosis, all of whom had titres of 1/ 125 or more against M. tuberculosis (Table II) . Thirty-six of these patients had two or more serum samples examined; 29 showed rising titres, the highest titre recorded being 1/2500. In general, the titres recorded in extrapulmonary disease were lower than those seen in pulmonary disease. Mycobacteria were isolated in this group between 17 and 111 days (median 32 days) after inoculation of the Lowenstein-Jensen slopes. Positive serology results were obtained between 2 and 80 days (median 28 days) before positive culture results in 35 of the 42 cases. In the remaining seven cases, positive results from both serology and culture were obtained at the same time. AAFB were reported in smears from 21 patients, and eight of these reports preceded reports of positive serological results.
Group II consists of 145 patients with a variety of diseases (Table III) all of whom had titres of less than 1/125 in initial and subsequent serum samples. No patient demonstrated a rising titre. No positive cultures were obtained from specimens examined from patients in this group. AAFB were seen in one sputum smear from one patient with old tuberculosis but repeated attempts to obtain the organism by culture were unsuccessful.
Four patients from whom cultures were obtained gave false negative serology results (group III, Table IV ). Three of these had pulmonary Twenty-four patients had positive serology but failed to provide positive cultures (Table V) . Definitive diagnoses other than tuberculosis were established in nine of the 24 cases, while a further nine were diagnosed as cases of tuberculosis, AAFB being seen in histological specimens. The remaining six were diagnosed as tuberculosis on clinical criteria and showed improvement with antituberculosis chemotherapy. In these six patients rising agglutinin titres were demonstrated within the first month of hospital admission in contrast with the non-tuberculous seropositive patients in whom titres remained static.
Group V consists of seven patients who had culture positive tuberculosis (Table VI) . In five patients the initial agglutinin titre was 1/50 while in the other two it was 1/25. All patients demonstrated a rising titre, which in five cases preceded the isolation of mycobacteria. Direct examination of sputum or biopsy material revealed AAFB or histological changes in four cases. In three cases this preceded the detection of a rising titre (Table VI) . DISCUSSION In order that this study might reflect the usefulness of the agglutination test in the clinical situation, only patients in whom tuberculosis was considered in the differential diagnosis were included. In all but one case (patient 5/1) no diagnosis had been confirmed when initial serological investigations were requested. Of the 222 patients, 13 had serological results at variance with conventional culture, histology or clinical findings. False negative results were recorded in four patients (group II, who has died showed no involvement of old tuberculous glands. Comparable information is not available from the remaining five patients. In none of these six patients was a rising titre observed, and in five the titre recorded was 1/ 125. In the 27 patients with tuberculosis none had a static titre at 1/125 although three had static titres of 1/250. The remaining three patients had chest radiograph shadows for which no explanation has been reached (Table III) . These patients had negative serological results, failed to yield positive culture after 12 weeks, had no malignant cells in sputum examination, and had no significant findings at bronchoscopy. This serological test therefore reliably distinguished between carcinoma and tuberculosis in 56 of 62 cases where the differential diagnosis was required, and eliminated the probability of tuberculosis far earlier than conventional methods from three other cases where a diagnosis had still not been made.
The level of significance for the agglutinin titre
(1/125) was made in an earlier study (Nicholls, 1975) and the findings of this study have not indicated that this level should be altered. The raising of the significance level to 1/250 would have eliminated 21 patients from group I (Table I) These results suggest that the agglutination test may be of clinical value in the diagnosis of tuberculosis, and it is difficult to explain why this test should appear to work when many other more sophisticated techniques have proved less reliable. Perhaps the most significant factor has been the use of an antigen free from autoagglutination. This has been achieved by treating the mycobacteria with sodium hydroxide (Nicholls, 1975) and allows the clear distinction between positive and negative reactions. It is also important that the agglutinin antibody is apparently not produced in response to BCG vaccination (Nicholls, unpublished data) and that it is relatively shortlived in high titre after active primary or post-primary disease. In successfully treated active disease, titres are elevated (above 1/125) for between 6 and 18 months and are generally below 1/125 at the cessation of chemotherapy. The persistence of an elevated titre may indicate the need for further therapy since three of four cases with titres of I/1125 or more at the end of treatment have relapsed within six months. It would seem that it is the quantity of antibody present which is important since it is obvious that a large number of people have detectable levels of specific agglutinin in the apparent absence of mycobacterial disease. 
